Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial.

Title:: Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial.
Document type:: Journal Article
Author(s):: Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M; Park, J; Hochhauser, D; Arnold, D; Oh, D; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E; McGuinness, D; Cui, K; Schlienger, K; Locker, G; Kindler, H
Journal title abbreviation:: Ann Oncol
Year:: 2019
Journal volume:: 30 Suppl 4
Fulltext / DOI:: doi:10.1093/annonc/mdz183
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/32085054
Print-ISSN:: 0923-7534
TUM Institution:: Lehrstuhl für Tumormetabolismus (Prof. Algül)
BibTeX

Occurrences: